Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fortress Biotech Inc Series A P

9.47
+0.72008.23%
Post-market: 9.470.00000.00%16:29 EDT
Volume:23.90K
Turnover:217.44K
Market Cap:477.89M
PE:-3.52
High:9.49
Open:8.84
Low:8.84
Close:8.75
Loading ...
Jan 27, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 21, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2023

Correspondence

Form CORRESP - Correspondence
Oct 26, 2023

Major Issues Report

Form 8-K - Current report
Oct 11, 2023

Major Issues Report

Form 8-K - Current report
Sep 30, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 30, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 27, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 19, 2023

Correspondence

Form CORRESP - Correspondence
Jul 06, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 23, 2023

Major Issues Report

Form 8-K - Current report